Veterinary Medicines

ACTI-STREPTO

Authorised
  • Dihydrostreptomycin sulfate
Download as PDF

Product identification

Medicine name:
ACTI-STREPTO
Active substance:
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle
  • Pig
  • Rabbit
  • Cattle (calf)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Dihydrostreptomycin sulfate
    626.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        14
        day
    • Rabbit
      • Meat and offal
        14
        day
    • Cattle (calf)
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Laboratoires Biove
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoires Biove
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2441413 9/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download